Allogene Therapeutics Inc (ALLO)
Financing Cash Flow
$220.09M
TTM · Period ending: · USD
ALLO Financing Cash Flow
Latest reported$220.09Mperiod ending
Latest reported$220.09Mperiod ending
ALLO TTM Cash from Financing ($771.18M → $220.09M)
TTM financing cash flow
High-resolution chart · PNG
ALLO financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 220,089,000 | |
| 37,289,000 | |
| 30,157,000 | |
| 28,041,000 | |
| 25,484,000 | |
| 129,015,000 | |
| 116,675,000 | |
| 111,087,000 | |
| 114,693,000 | |
| 95,614,000 | |
| 95,695,000 | |
| 95,586,000 | |
| 92,367,000 | |
| 2,867,000 | |
| 2,950,000 | |
| 3,226,000 | |
| 4,543,000 | |
| 7,733,000 | |
| 11,963,000 | |
| 24,619,000 | |
| 26,088,000 | |
| 623,049,000 | |
| 633,591,000 | |
| 677,087,000 | |
| 674,801,000 | |
| 74,862,000 | |
| 58,960,000 | |
| 347,008,000 | |
| 619,499,000 | |
| 771,866,000 | |
| 771,182,000 | |
| 426,660,000 |